Genetically modeled mice with mutations in mitochondrial metabolic enzymes for the study of cancer

Frontiers in Oncology

Volumn 4 JUL, Issue , 2014, Pages

  Piruat, José I ^a   Millán Uclés, África ^a  

^a Instituto de Biomedicina de Sevilla   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; FUMARATE HYDRATASE; HISTONE DEMETHYLASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOCITRATE DEHYDROGENASE; MITOCHONDRIAL ENZYME; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE;

ACUTE GRANULOCYTIC LEUKEMIA; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DYSPLASIA; EXTRAMEDULLARY HEMATOPOIESIS; GLYCOLYSIS; HEMATOPOIETIC STEM CELL; KIDNEY CARCINOMA; LEIOMYOMATOSIS; LIPID PEROXIDATION; MOUSE; MUTATION; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXIDATIVE STRESS; PHEOCHROMOCYTOMA; TESTIS CANCER;

EID: 84904915102     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00200     Document Type: Article

References (85)

1. Abbas, T., and Dutta, A. (2009). p21 in cancer: intricate networks and multiple activities. Nature reviews Cancer 9, 400-414.
2. Adam, J., Hatipoglu, E., O'Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H., Baban, D., Nye, E., Stamp, G.W., Wolhuter, K., et al. (2013). Renal cyst formation in Fh1- deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer cell 20, 524-537.
3. Ashrafian, H., O'Flaherty, L., Adam, J., Steeples, V., Chung, Y.L., East, P., Vanharanta, S., Lehtonen, H., Nye, E., Hatipoglu, E., et al. (2010). Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis. Cancer research 70, 9153-9165.
4. Astuti, D., Latif, F., Dallol, A., Dahia, P.L., Douglas, F., George, E., Skoldberg, F., Husebye, E.S., Eng, C., and Maher, E.R. (2001). Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American journal of human genetics 69, 49-54.
5. Bacon, A.L., and Harris, A.L. (2004). Hypoxia-inducible factors and hypoxic cell death in tumour physiology. Annals of medicine 36, 530-539.
6. Bardella, C., El-Bahrawy, M., Frizzell, N., Adam, J., Ternette, N., Hatipoglu, E., Howarth, K., O'Flaherty, L., Roberts, I., Turner, G., et al. (2011). Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. The Journal of pathology 225, 4-11.
7. Bayley, J.P., van Minderhout, I., Hogendoorn, P.C., Cornelisse, C.J., van der Wal, A., Prins, F.A., Teppema, L., Dahan, A., Devilee, P., and Taschner, P.E. (2009). Sdhd and SDHD/H19 knockout mice do not develop paraganglioma or pheochromocytoma. PloS one 4, e7987.
8. Baysal, B.E. (2013). Mitochondrial complex II and genomic imprinting in inheritance of paraganglioma tumors. Biochimica et biophysica acta. 1827, 573-577.
9. Baysal, B.E. (2007). A recurrent stop-codon mutation in succinate dehydrogenase subunit B gene in normal peripheral blood and childhood T-cell acute leukemia. PloS one 2, e436.
10. Baysal, B.E. (2008). Clinical and molecular progress in hereditary paraganglioma. Journal of medical genetics 45, 689-694.
11. Baysal, B.E., Ferrell, R.E., Willett-Brozick, J.E., Lawrence, E.C., Myssiorek, D., Bosch, A., van der Mey, A., Taschner, P.E., Rubinstein, W.S., Myers, E.N., et al. (2000). Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848-851.
12. Briere, J.J., Favier, J., Benit, P., El Ghouzzi, V., Lorenzato, A., Rabier, D., Di Renzo, M.F., Gimenez-Roqueplo, A.P., and Rustin, P. (2005). Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions. Human molecular genetics 14, 3263-3269.
13. Burnichon, N., Briere, J.J., Libe, R., Vescovo, L., Riviere, J., Tissier, F., Jouanno, E., Jeunemaitre, X., Benit, P., Tzagoloff, A., et al. (2010). SDHA is a tumor suppressor gene causing paraganglioma. Human molecular genetics 19, 3011-3020.
14. Cairns, R.A., and Mak, T.W. (2013). Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. Cancer discovery 3, 730-741.
15. Carvajal-Carmona, L.G., Alam, N.A., Pollard, P.J., Jones, A.M., Barclay, E., Wortham, N., Pignatelli, M., Freeman, A., Pomplun, S., Ellis, I., et al. (2006). Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations. The Journal of clinical endocrinology and metabolism 91, 3071-3075.
16. Cervera, A.M., Bayley, J.P., Devilee, P., and McCreath, K.J. (2009). Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Molecular cancer 8, 89.
17. Chen, C., Liu, Y., Lu, C., Cross, J.R., Morris, J.P.t., Shroff, A.S., Ward, P.S., Bradner, J.E., Thompson, C., and Lowe, S.W. (2013). Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition. Genes & development 27, 1974-1985.
18. Chin, R.M., Fu, X., Pai, M.Y., Vergnes, L., Hwang, H., Deng, G., Diep, S., Lomenick, B., Meli, V.S., Monsalve, G.C, et al (2014) The metabolite a-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature 509, 397-401.
19. Dahia, P.L. (2006). Evolving concepts in pheochromocytoma and paraganglioma. Current opinion in oncology 18, 1-8.
20. Dahia, P.L., Ross, K.N., Wright, M.E., Hayashida, C.Y., Santagata, S., Barontini, M., Kung, A.L., Sanso, G., Powers, J.F., Tischler, A.S., et al. (2005). A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS genetics 1, 72-80.
21. Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M. A., Driggers, E.M., Fantin, V.R., Jang, H.G., Jin, S., Keenan, M.C., et al. (2009). Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744.
22. Denko, N.C. (2008). Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nature reviews Cancer 8, 705-713.
23. Diaz-Castro, B., Pintado, C.O., Garcia-Flores, P., Lopez-Barneo, J., and Piruat, J.I. (2012). Differential impairment of catecholaminergic cell maturation and survival by genetic mitochondrial complex II dysfunction. Molecular and cellular biology 32, 3347- 3357.
24. DiMauro, S., and Schon, E.A. (2003). Mitochondrial respiratory-chain diseases. The New England journal of medicine 348, 2656-2668.
25. Figueroa, M.E., Abdel-Wahab, O., Lu, C., Ward, P.S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H.F., et al. (2010). Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer cell 18, 553-567.
26. Gill, A.J. (2012). Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology 44, 285-292.
27. Gottlieb, E., and Tomlinson, I.P. (2005). Mitochondrial tumour suppressors: a genetic and biochemical update. Nature reviews Cancer 5, 857-866.
28. Guzy, R.D., Sharma, B., Bell, E., Chandel, N.S., and Schumacker, P.T. (2008). Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species647 dependent hypoxia-inducible factor activation and tumorigenesis. Molecular and cellular biology 28, 718-731.
29. Hao, H.X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J.P., Kunst, H., Devilee, P., Cremers, C.W., Schiffman, J.D., Bentz, B.G., et al. (2009). SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325, 1139-1142.
30. Hederstedt, L. (2003). Structural biology. Complex II is complex too. Science 299, 671- 672.
31. Hensen, E.F., Jordanova, E.S., van Minderhout, I.J., Hogendoorn, P. C., Taschner, P.E., van der Mey, A.G., Devilee, P., and Cornelisse, C.J. (2004). Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 23, 4076-4083.
32. Hewitson, K.S., Lienard, B.M., McDonough, M.A., Clifton, I.J., Butler, D., Soares, A.S., Oldham, N.J., McNeill, L.A., and Schofield, C.J. (2007). Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. The Journal of biological chemistry 282, 3293-3301.
33. Isaacs, J.S., Jung, Y.J., Mole, D.R., Lee, S., Torres-Cabala, C., Chung, Y.L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer cell 8, 143-153.
34. Ishii, T., Miyazawa, M., Onodera, A., Yasuda, K., Kawabe, N., Kirinashizawa, M., Yoshimura, S., Maruyama, N., Hartman, P.S., and Ishii, N. (2011). Mitochondrial reactive oxygen species generation by the SDHC V69E mutation causes low birth weight and neonatal growth retardation. Mitochondrion 11, 155-165.
35. Ishii, T., Yasuda, K., Akatsuka, A., Hino, O., Hartman, P.S., and Ishii, N. (2005). A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer research 65, 203-209.
36. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J.M., Lane, W.S., and Kaelin, W.G., Jr. (2001). HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (New York, NY 292, 464-468.
37. Jaakkola, P., Mole, D.R., Tian, Y.M., Wilson, M.I., Gielbert, J., Gaskell, S.J., von Kriegsheim, A., Hebestreit, H.F., Mukherji, M., Schofield, C.J., et al. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (New York, NY 292, 468-472.
38. Jeganathan, K., Malureanu, L., Baker, D.J., Abraham, S.C., and van Deursen, J.M. (2007). Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. The Journal of cell biology 179, 255-267.
39. Kats, L.M., Reschke, M., Taulli, R., Pozdnyakova, O., Burgess, K., Bhargava, P., Straley, K., Karnik, R., Meissner, A., Small D., et al. (2014). Proto-Oncogenic Role of Mutant IDH2 in Leukemia Initiation and Maintenance. Cell Stem Cell 14, 329-341.
40. Kim, W., and Liau, L.M. (2012). IDH mutations in human glioma. Neurosurgery clinics of North America 23, 471-480.
41. Kiuru, M., and Launonen, V. (2004). Hereditary leiomyomatosis and renal cell cancer (HLRCC). Current molecular medicine 4, 869-875.
42. Koivunen, P., Hirsila, M., Remes, A.M., Hassinen, I.E., Kivirikko, K.I., and Myllyharju, J. (2007). Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. The Journal of biological chemistry 282, 4524-4532.
43. Koivunen, P., Lee, S., Duncan, C.G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J.A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012). Transformation by the (R)- enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483, 484-488.
44. Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., van Gessel, B., Oudijk, L., Badoual, C., Gadessaud, N., Venisse, A., Bayley, J.P., et al. (2012). SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. The Journal of clinical endocrinology and metabolism 96, E1472-1476.
45. Lehtonen, H.J. (2011). Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Familial cancer 10, 397-411.
46. Letouze, E., Martinelli,C., Loriot, C., Burnichon, N., Abermil, N.,Ottolenghi, C., Janin, M., Menara, M., Nguyen, A.T., Paule Benit, P., et al. (2013). SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma. Cancer Cell 23, 739-752.
47. Malinoc, A., Sullivan, M., Wiech, T., Kurt Werner, S., Jilg, C., Straeter, J., Deger, S., Hoffmann, M.M., Bosse, A., Rasp, G., et al. (2012). Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3. Endocrine- related cancer 19, 283-290.
48. Maxwell, P.H. (2005). Hypoxia-inducible factor as a physiological regulator. Experimental physiology 90, 791-797.
49. Millán-Uclés, A., Díaz-Castro, B., García-Flores, P., Báez, A., Pérez-Simón, J.A., López-Barneo, J., and Piruat, J.I. (2014). A conditional mouse mutant in the tumor suppressor SdhD gene unveils a link between p21(WAF1/Cip1) induction and mitochondrial dysfunction. PloS one 9, e85528.
50. Niemann, S., and Muller, U. (2000). Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature genetics 26, 268-270.
51. Oudijk, L., Gaal, J., Korpershoek, E., van Nederveen, F.H., Kelly, L., Schiavon, G., Verweij, J., Mathijssen, R.H., den Bakker, M.A., Oldenburg, R.A., et al. (2013). SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors. Mod Pathol 26, 456-463.
52. Papathomas, T.G., de Krijger, R.R., and Tischler, A.S. (2013). Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments. Seminars in diagnostic pathology 30, 207-223.
53. Picaud, S., Kavanagh, K.L., Yue, W.W., Lee, W.H., Muller-Knapp, S., Gileadi, O., Sacchettini, J., and Oppermann, U. (2011). Structural basis of fumarate hydratase deficiency. Journal of inherited metabolic disease 34, 671-676.
54. Piruat, J.I., Pintado, C.O., Ortega-Sáenz, P., Roche, M., and López-Barneo, J. (2004). The mitochondrial SDHD gene is required for early embryogenesis, and its partial deficiency results in persistent carotid body glomus cell activation with full responsiveness to hypoxia. Molecular and cellular biology 24, 10933-10940.
55. Platero-Luengo, A., González-Granero, S., Durán, R., Díaz-Castro, B., Piruat, J.I., García-Verdugo, J.M., Pardal, R., and López-Barneo, J. (2014). An O2-sensitive glomus cell-stem cell synapse induces carotid body growth in chronic hypoxia. Cell 156, 291-303.
56. Pollard, P.J., Briere, J.J., Alam, N.A., Barwell, J., Barclay, E., Wortham, N.C., Hunt, T., Mitchell, M., Olpin, S., Moat, S.J., et al. (2005). Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Human molecular genetics 14, 2231-2239.
57. Pollard, P.J., Spencer-Dene, B., Shukla, D., Howarth, K., Nye, E., El-Bahrawy, M., Deheragoda, M., Joannou, M., McDonald, S., Martin, A., et al. (2007). Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. Cancer cell 11, 311-319.
58. Rakheja, D., Konoplev, S., Medeiros, L.J., and Chen, W. (2012). IDH mutations in acute myeloid leukemia. Human pathology 43, 1541-1551.
59. Ricketts, C.J., Shuch, B., Vocke, C.D., Metwalli, A.R., Bratslavsky, G., Middelton, L., Yang, Y., Wei, M.H., Pautler, S.E., Peterson, J., et al. (2012). Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. The Journal of urology 188, 2063-2071.
60. Romanov, V.S., Pospelov, V.A., and Pospelova, T.V. (2012). Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry 77, 575-584.
61. Rose, N.R., McDonough, M.A., King, O.N., Kawamura, A., and Schofield, C.J. (2011). Inhibition of 2-oxoglutarate dependent oxygenases. Chemical Society reviews 40, 4364- 4397.
62. Sasaki, M., Knobbe, C.B., Itsumi, M., Elia, A.J., Harris, I.S., Chio, II, Cairns, R.A., McCracken, S., Wakeham, A., Haight, J., et al. (2012a). D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function. Genes & development 26, 2038-2049.
63. Sasaki, M., Knobbe, C.B., Munger, J.C., Lind, E.F., Brenner, D., Brustle, A., Harris, I.S., Holmes, R., Wakeham, A., Haight, J., et al. (2012b). IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488, 656- 659.
64. Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D., Pan, Y., Simon, M.C., Thompson, C.B., and Gottlieb, E. (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer cell 7, 77-85.
65. Semenza, G.L., Roth, P.H., Fang, H.M., and Wang, G.L. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. The Journal of biological chemistry 269, 23757-23763.
66. Senoo-Matsuda, N., Hartman, P.S., Akatsuka, A., Yoshimura, S., and Ishii, N. (2003). A complex II defect affects mitochondrial structure, leading to ced-3- and ced-4- dependent apoptosis and aging. The Journal of biological chemistry 278, 22031-22036.
67. Smith, E.H., Janknecht, R., and Maher, L.J., 3rd (2007). Succinate inhibition of alpha ketoglutarate-dependent enzymes in a yeast model of paraganglioma. Human molecular. genetics 16, 3136-3148.
68. Smith, B.W., Rueter, E.M., Becker, N.A., Bida, J.P., Nelson-Holte, M., et 699 al. (2011) Mouse Models of Human Familial Paraganglioma, Pheochromocytoma - A New View of the Old Problem, Dr. Jose Fernando Martin (Ed.), ISBN: 978-953-307-822-9, InTech. DOI: 10.5772/25346. Available from: http://www.intechopen.com/books/pheochromocytoma-a-new-view-of-the-old78 6 problem/mouse-models-of-human-familial paraganglioma
69. Stratakis, C.A., and Carney, J.A. (2009). The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. Journal of internal medicine 266, 43-52.
70. Sudarshan, S., Sourbier, C., Kong, H.S., Block, K., Valera Romero, V.A., Yang, Y., Galindo, C., Mollapour, M., Scroggins, B., Goode, N., et al. (2009). Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Molecular and cellular biology 29, 4080-4090.
71. Sun, F., Huo, X., Zhai, Y., Wang, A., Xu, J., Su, D., Bartlam, M., and Rao, Z. (2005). Crystal structure of mitochondrial respiratory membrane protein complex II. Cell 121, 1043-1057.
72. Timmers, H.J., Gimenez-Roqueplo, A.P., Mannelli, M., and Pacak, K. (2009). Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocrine-related cancer 16, 391-400.
73. Tarhonskaya, H., Rydzik, A.M., Leung, I.K., Loik, N.D., Chan, M.C., Kawamura, A., McCullagh, J.S., Claridge, T.D., Flashman, E., Schofield, C.J. (2014). Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases. Nat Commun 5:3423.
74. Tomlinson, I.P., Alam, N.A., Rowan, A.J., Barclay, E., Jaeger, E.E., Kelsell, D., Leigh, I., Gorman, P., Lamlum, H., Rahman, S., et al. (2002). Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nature genetics 30, 406-410.
75. Vanharanta, S., Buchta, M., McWhinney, S.R., Virta, S.K., Peczkowska, M., Morrison, C.D., Lehtonen, R., Januszewicz, A., Jarvinen, H., Juhola, M., et al. (2004). Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. American journal of human genetics 74, 153-159.
76. Wang, G.L., Jiang, B.H., Rue, E.A., and Semenza, G.L. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America 92, 5510-5514.
77. Ward, P.S., Patel, J., Wise, D.R., Abdel-Wahab, O., Bennett, B.D., Coller, H.A., Cross, J.R., Fantin, V.R., Hedvat, C.V., Perl, A.E., et al. (2010). The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer cell 17, 225-234.
78. Waypa, G.B., Guzy, R., Mungai, P.T., Mack, M.M., Marks, J.D., Roe, M.W., and Schumacker, P.T. (2006). Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells. Circulation research 99, 970-978.
79. Xekouki, P., Pacak, K., Almeida, M., Wassif, C.A., Rustin, P., Nesterova, M., de la Luz Sierra, M., Matro, J., Ball, E., Azevedo, M., et al. (2012). Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? The Journal of clinical endocrinology and metabolism 97, E357-366.
80. Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., et al. (2012). Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes & development 26, 1326-1338.
81. Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.H., Ito, S., Yang, C., Wang, P., Xiao, M.T., et al. (2011). Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer cell 19, 17-30.
82. Yan, H., Parsons, D.W., Jin, G., McLendon, R., Rasheed, B.A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G.J., et al. (2009). IDH1 and IDH2 mutations in gliomas. The New England journal of medicine 360, 765-773.
83. Yankovskaya, V., Horsefield, R., Tornroth, S., Luna-Chavez, C., Miyoshi, H., Leger, C., Byrne, B., Cecchini, G., and Iwata, S. (2003). Architecture of succinate dehydrogenase and reactive oxygen species generation. Science (New York, NY 299, 700-704.
84. Zhang, D.D. (2006). Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug metabolism reviews 38, 769-789.
85. Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009). Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324, 261-265.